Saquinavir in the management of HIV infection

British Journal of Hospital Medicine

Volumn 57, Issue 11, 1997, Pages 560-564

  Moyle, Graeme ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; SAQUINAVIR;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG COMBINATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; SAQUINAVIR; VIRUS REPLICATION;

EID: 0031552503     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Baruch A, Mastrodonanto-Delora P, Schnipper E, Salgo M (1996) Efficacy and safety of triple combination therapy with Invirase (saquinavir/SQV/HIV protease inhibitor). Epivir (3TC/lamivudine) and Retrovir (ZDV/zidovudine). IXth Conference on AIDS, Vancouver. Abstract Mo B 172
2. Cameron W, Sun E, Markowitz M et al (1996) Combination use of ritonavir and saquinavir in HlV-infected patients: preliminary safety and activity data. Improved survival and decreased disease progression of HIV in patients treated with saquinavir plus HIVID. XI International Conference on AIDS, Vancouver. Abstract Th. B.934
3. Collier AC, Coombs RW, Schoenfeld DA et al (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabme. N Eng! J Med 334: 1011-17
4. Condra JH, Schleif WA, Blahy OM et al (1995) In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374: 569-71
5. Gazzard B, Moyle G (1997) To sequence or not to sequence? Exp Opin Invest Drugs 6: 99-102
6. Gazzard; BG, Moyle GJ, Weber J et al (1997) British HIV Association Guidelines for Antiretroviral Treatment of HIV seropositive individuals. Lancet 349: 1086-92
7. Lalezari J, Haubrich R, Burger HU et al (1996) Improved survival and decreased progression of HIV in patients treated with saquinavir (Invirase, SQV) plus HIVID (zalcitabine, ddC). IXth Conference on AIDS, Vancouver. Abstract LB B6033
8. Movie G (1996a) Saquinavir: a review of its development, pharmacological properties and clinical use. Exp Opin Invest Drugs 5: 155-67
9. Moyle GJ (1996b) Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences. Drugs 52: 168-85
10. Sahai J (1996) Risks and synergies from drug interactions. AIDS 10 (suppll): S21-S25
11. Schapiro JM, winters MA, Stewart F et al (1996) The effect of high dose saquinavir on viral load and CD4 T cell counts in HIV infected patients. Ann Intern Med 124: 1039-50